Prescribed since 1948 to control chronic alcoholism, disulfiram may ca
use severe toxicity as report in three cases of acute motive axonal po
lyneuritis. Disulfiram toxicity may present different clinical aspects
: 1) Cytolytic hepatitis with fatal evolution in 30% of cases (fulmin
ant hepatitis), and full recovery for the other 70%. The onset of the
symptoms usually occurs as early as 15 days to a maximum of 6 months (
most within 2 months) after initiation of treatment. 2) Severe optic n
euritis with full recovery in 2 months. 3) Peripheral neuropathy usual
ly dose dependant, with different clinical presentations : polyneuriti
s with sensory, motor, or both deficits, and few cases of tetraplegia.
4) Encephalopathy frequently associated with one of the precedent sym
ptoms, having a favorable outcome (probably resulting in inhibition of
dopamine-beta-hydroxylase by disulfiram). The mechanism of toxicity (
direct or idiosyncratic) remain unclear. Disulfiram has been used safe
ly in millions of people since 1948, and we have only few cases report
s of severe toxicity. From a practical point of view, treated patients
should benefit by a neurological examination once a month, ophtalmolo
gical examination every 2 months, and hepatic enzymes monitored twice
a month during the 2 first months. This is the price to prevent and to
detect side effects of disulfiram therapy.